These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

424 related items for PubMed ID: 9398006

  • 1. Nucleotide sequence variations in the internal ribosome entry site of hepatitis C virus-1b: no association with efficacy of interferon therapy or serum HCV-RNA levels.
    Yamamoto C, Enomoto N, Kurosaki M, Yu SH, Tazawa J, Izumi N, Marumo F, Sato C.
    Hepatology; 1997 Dec; 26(6):1616-20. PubMed ID: 9398006
    [Abstract] [Full Text] [Related]

  • 2. Correlation between translation efficiency and outcome of combination therapy in chronic hepatitis C genotype 3.
    Yasmeen A, Hamid S, Granath FN, Lindström H, Elliott RM, Siddiqui AA, Persson MA.
    J Viral Hepat; 2006 Feb; 13(2):87-95. PubMed ID: 16436126
    [Abstract] [Full Text] [Related]

  • 3. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection.
    Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Ogura Y, Izumi N, Marumo F, Sato C.
    N Engl J Med; 1996 Jan 11; 334(2):77-81. PubMed ID: 8531962
    [Abstract] [Full Text] [Related]

  • 4. Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa.
    Zeuzem S, Lee JH, Roth WK.
    Hepatology; 1997 Mar 11; 25(3):740-4. PubMed ID: 9049228
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection.
    Weiland O, Chen M, Lindh G, Mattsson L, Schvarcz R, Sönnerborg A, Wahl M, Wejstål R, Widell A, Norkrans G.
    Scand J Infect Dis; 1995 Mar 11; 27(5):319-24. PubMed ID: 8588128
    [Abstract] [Full Text] [Related]

  • 6. Analysis of genotypes and amino acid residues 2209 to 2248 of the NS5A region of hepatitis C virus in relation to the response to interferon-beta therapy.
    Kurosaki M, Enomoto N, Murakami T, Sakuma I, Asahina Y, Yamamoto C, Ikeda T, Tozuka S, Izumi N, Marumo F, Sato C.
    Hepatology; 1997 Mar 11; 25(3):750-3. PubMed ID: 9049230
    [Abstract] [Full Text] [Related]

  • 7. Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection.
    Chayama K, Tsubota A, Kobayashi M, Okamoto K, Hashimoto M, Miyano Y, Koike H, Kobayashi M, Koida I, Arase Y, Saitoh S, Suzuki Y, Murashima N, Ikeda K, Kumada H.
    Hepatology; 1997 Mar 11; 25(3):745-9. PubMed ID: 9049229
    [Abstract] [Full Text] [Related]

  • 8. Predictors of the efficacy of intravenous natural interferon-beta treatment in chronic hepatitis C.
    Fukutomi T, Fukutomi M, Iwao M, Watanabe H, Tanabe Y, Hiroshige K, Kinukawa N, Nakamuta M, Nawata H.
    Med Sci Monit; 2000 Mar 11; 6(4):692-8. PubMed ID: 11208393
    [Abstract] [Full Text] [Related]

  • 9. Patterns of hepatitis C viremia in patients receiving hemodialysis.
    Umlauft F, Gruenewald K, Weiss G, Kessler H, Urbanek M, Haun M, Santner B, Koenig P, Keeffe EB.
    Am J Gastroenterol; 1997 Jan 11; 92(1):73-8. PubMed ID: 8995941
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Interferon sensitivity-determining region of nonstructural region 5A of hepatitis C virus genotype 1b correlates with serum alanine aminotransferase levels in chronic infection.
    Yoshioka K, Ito H, Watanabe K, Yano M, Ishigami M, Mizutani T, Sasaki Y, Goto H.
    J Viral Hepat; 2005 Mar 11; 12(2):139-45. PubMed ID: 15720528
    [Abstract] [Full Text] [Related]

  • 12. Hepatic expression of hepatitis C virus RNA in chronic hepatitis C: a study by in situ reverse-transcription polymerase chain reaction.
    Lau GK, Davis GL, Wu SP, Gish RG, Balart LA, Lau JY.
    Hepatology; 1996 Jun 11; 23(6):1318-23. PubMed ID: 8675145
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Association with 5'-untranslated region and response to interferon in chronic hepatitis C.
    Katano Y, Hayashi K, Ishigami M, Itoh A, Hirooka Y, Nakano I, Goto H.
    Hepatogastroenterology; 2007 Jun 11; 54(75):854-7. PubMed ID: 17591078
    [Abstract] [Full Text] [Related]

  • 15. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.
    Czerwionka-Szaflarska M, Chrobot A, Szaflarska-Szczepanik A.
    Med Sci Monit; 2000 Jun 11; 6(5):964-70. PubMed ID: 11208439
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C.
    Martinot-Peignoux M, Marcellin P, Pouteau M, Castelnau C, Boyer N, Poliquin M, Degott C, Descombes I, Le Breton V, Milotova V.
    Hepatology; 1995 Oct 11; 22(4 Pt 1):1050-6. PubMed ID: 7557850
    [Abstract] [Full Text] [Related]

  • 20. Intrahepatic hepatitis C RNA levels do not correlate with degree of liver injury in patients with chronic hepatitis C.
    McGuinness PH, Bishop GA, Painter DM, Chan R, McCaughan GW.
    Hepatology; 1996 Apr 11; 23(4):676-87. PubMed ID: 8666317
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.